Skip to main content
Top

Familial Cancer

Issue 1/2005

Content (12 Articles)

Pheochromocytoma – where are we? Where should we go? A medical and scientific odyssey

Hartmut P. H. Neumann, Giuseppe Opocher, Andrzej Januszewicz, Charis Eng

SDHC mutations in hereditary paraganglioma/pheochromocytoma

Ulrich Müller, Christian Troidl, Stephan Niemann

Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1

Giuseppe Opocher, Pierantonio Conton, Francesca Schiavi, Beatrice Macino, Franco Mantero

Multiple endocrine neoplasia type 2

Mariola Peczkowska, Andrzej Januszewicz

Review

Mutations of the SDHB and SDHD genes

Christian Pawlu, Birke Bausch, Hartmut P. H. Neumann

Review

Paragangliomas of the head and neck: diagnosis and treatment

C. C. Boedeker, G. J. Ridder, J. Schipper

Imaging of pheochromocytoma and paraganglioma

I. Brink, S. Hoegerle, J. Klisch, T. A. Bley

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine